G., Yang, J., Santra, S., Santra, S., Chopp, M., & Morris, D
But as the use of weight loss medications grows, understanding what your body needs to stay fueled without triggering unwanted side effects (like stalled weight loss or GI upset) is vital
While we lack definitive RCT data, there is a strong physiological rationale and emerging real-world experience suggesting benefits from tapering doses (e.g., 15 12.5 10 2.5 mg) before stopping: Allows neurohormonal pathways to recalibrate gradually rather than abruptly Provides a window to stabilize lifestyle adjustments at each step May help identify a lowest effective maintenance dose that sustains satiety signals Reduces the shock of withdrawal, lowering the risk of rapid rebound Key takeaway: The narrative that all patients regain weight after GLP-1/GIP therapy overlooks an important nuance: regain has been observed when treatment is stopped suddenly at high doses
This was in the early 1990s